Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Selsted
University of Southern California, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Oryn Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Intellectual property licensed to Oryn Therapeutics is under study in this research project.
Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections
This research seeks to develop new therapies against multidrug resistant pathogenic bacteria (MDR) by en- hancing the ability of the host immune system to neutralize and clear infections. Bacteria with resistance to the carbapenem class of antibiotics pose a major and urgent public health threat, because carbapenems are drugs of last resort for treating MDR infections. We predict that the lead therapeutic peptide will be efficacious, be- cause its immune modulating properties will augment immunity independent of bacterial factors that underlie antibiotic resistance.
Filed on February 28, 2019.
Tell us what you know about Michael Selsted's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Selsted filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Selsted | University of Southern California | Conflict of Interest | Resolve Therapeutics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.